INFANTILE HEMANGIOMA (IH)
Clinical trials for INFANTILE HEMANGIOMA (IH) explained in plain language.
Never miss a new study
Get alerted when new INFANTILE HEMANGIOMA (IH) trials appear
Sign up with your email to follow new studies for INFANTILE HEMANGIOMA (IH), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Stopping hemangioma drug abruptly may be as safe as tapering
Disease control Not yet recruitingThis study looks at whether stopping propranolol suddenly or slowly is better for preventing hemangioma regrowth in infants. About 110 children who have taken propranolol for at least 6 months will be randomly assigned to either stop immediately or taper over 4 weeks. The goal is…
Matched conditions: INFANTILE HEMANGIOMA (IH)
Phase: PHASE4 • Sponsor: West China Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New study aims to tell which baby birthmarks need treatment
Knowledge-focused Not yet recruitingThis study will follow 150 infants with a type of birthmark called infantile hemangioma. Some have a less active form that barely grows, while others have the typical form. Doctors will assess each baby using standard guidelines and decide whether to recommend treatment or just w…
Matched conditions: INFANTILE HEMANGIOMA (IH)
Sponsor: West China Hospital • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC